Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 15th Jan 2013 07:17

African Barrick Gold: Investec lowers its target price from 526p to 405p, while upgrading from hold to buy.ARM Holdings: Morgan Stanley raises its target price from 725p to 911p, while downgrading to equal-weight. Investec ups target price from 800p to 900p and downgrades from buy to hold.Aurum Mining: WH Ireland starts with a target price of 4.70p and a speculative buy.Barclays: JP Morgan increases target price from 320p to 350p and retains an overweight rating.Burberry: Bank of America raises target price from 1260p to 1470p and upgrades to buy.Cable & Wireless Communications: Berenberg moves target price from 38p to 40p, while its hold recommendation remains unchanged.Capital Shopping Centres Group: Espirito Santo reduces target price from 328p to 320p and downgrades to sell.Carnival: Investec shifts target price from 2950p to 3000p staying with its buy recommendation.Centamin: Numis upgrades from add to buy.Chariot Oil & Gas: Seymour Pierce cuts target price from 31p to 26p and downgrades from hold to sell.Croda International: Bank of America ups target price from 2350p to 2500p staying with its buy recommendation.easyJet: Bank of America raises target price from 695p to 910p, while its neutral rating remains unchanged.Eland Oil & Gas: Northland Capital starts with a target price of 171p and a buy recommendation.Elementis: Bank of America initiates with an underperform rating.Essar Energy: Barclays Capital reduces target price from 180p to 170p maintaining an overweight rating.Evraz Group: Deutsche Bank lowers target price from 389p to 311p and reiterates a buy recommendation.Halfords Group: Investec takes target price from 360p to 385p keeping a buy rating.Hammerson: Espirito Santo increases its target price from 473p to 525p, while the neutral rating is kept.Hikma Pharmaceuticals: Jefferies raises target price from 890p to 900p and reiterates a buy recommendation.HSBC Holdings: Credit Suisse moves its target price from 700p to 750p, while the outperform rating is maintained. JP Morgan ups target price from 650p to 7725p and stays with its overweight rating.InterContinental Hotels Group: Panmure Gordon raises target price from 1670p to 1724p and reiterates a hold rating.Interserve: UBS takes its target price from 315p to 345p retaining a sell rating.ITV: UBS increases target price from 110p to 145p and still recommends to buy.Johnson Matthey: Bank of America raises target price from 2375p to 2500p keeping a neutral rating.Lancashire: Credit Suisse upgrades from neutral to outperform.Lavendon: Panmure Gordon shifts target price from 160p to 164p and downgrades from buy to hold.Lloyds Banking Group: JP Morgan takes target price from 38p to 55p and upgrades to neutral.Mears Group: Investec increases target price from 325p to 400p maintaining a buy recommendation.Moss Bross: Seymour Pierce ups target price from 55p to 65p keeping its hold rating.New World Resources: Bank of America lowers target price from 175p to 155p, while its underperform rating remains unchanged.Pearson: UBS moves target price from 1450p to 1500p and stays with its buy recommendation.Pennon Group: Societe Generale starts with a target price of 696p and a hold recommendation.Redefine International: Investec shifts its target price from 36p to 38p staying with buy rating.Rialto Energy: Investec moves its target price from 12.64p to 13p and upgrades from hold to buy.Royal Bank of Scotland: Credit Suisse raises target price from 220p to 250p, while reiterating an underperform rating. JP Morgan increases its target price from 270p to 415p and upgrades to overweight.Segro: Barclays Capital cuts target price from 311p to 270p and downgrades from overweight to equal-weight.Severn Trent: Societe Generale initiates with its target price at 1504p and a hold rating.Smith & Nephew: Barclays Capital takes price target from 665p to 717p, while its equal-weight rating is kept.Standart Chartered: Credit Suisse ups target price from 1340p to 1400p and retains an underperform rating. JP Morgan increases target price from 1800p to 1900p, while keeping an overweight rating.Synthomer: Bank of America moves target price from 193p to 220p, while its buy recommendation is unchanged.Tullow Oil: Deutsche Bank reduces target price from 1120p to 1105p and keeps a hold rating.UBM: UBS raises target price from 660p to 720p keeping a neutral rating.United Utilities: Societe Generale starts with a target price of 779p and recommends to buy.WANdisco: Panmure Gordon ups target price from 537p to 565p, while downgrading from buy to hold.WPP Group: Liberum Capital increases target price from 1100p to 1180p and maintains a buy recommendation.
More News
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.